Both in Pharmaceuticals
CDT Equity vs Kyntra Bio
Over the past year CDT returned −99.5% and KYNB returned −27.4%; their daily moves had a correlation of -0.06.
CDT −99.5% KYNB −27.4%Growth of $1, one year, split-adjusted
| Metric | CDT | KYNB |
|---|---|---|
| Price | $1.90 | $6.90 |
| Market cap | $26.0M | $27.9M |
| Today | +2275.00% | −0.58% |
| 1 month | +1.1% | −13.8% |
| 6 months | −97.6% | +4.7% |
| Year to date | −99.4% | — |
| 1 year | −99.9% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$390.0K | $91.3M |
| Dividend yield | — | — |
| Volatility (60d) | 932.2% | 41.4% |
| Short % of float | 34.8% | 2.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).